{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:50:04Z","timestamp":1775598604319,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","award":["PAJT"],"award-info":[{"award-number":["PAJT"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010688","name":"Instituto Nacional de Ci\u00eancia e Tecnologia da Criosfera","doi-asserted-by":"publisher","award":["INCT-EN for Excitotoxicity and Neuroprotection"],"award-info":[{"award-number":["INCT-EN for Excitotoxicity and Neuroprotection"]}],"id":[{"id":"10.13039\/501100010688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["PDSE 47\/2017"],"award-info":[{"award-number":["PDSE 47\/2017"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005667","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Estado de Santa Catarina","doi-asserted-by":"publisher","award":["NENASC\/ PRONEX"],"award-info":[{"award-number":["NENASC\/ PRONEX"]}],"id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["SAF2017-87349-R"],"award-info":[{"award-number":["SAF2017-87349-R"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["ISCIII-PIE14\/00034"],"award-info":[{"award-number":["ISCIII-PIE14\/00034"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["Grant 20152031"],"award-info":[{"award-number":["Grant 20152031"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017 SGR 1604"],"award-info":[{"award-number":["2017 SGR 1604"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FWO","award":["SBO-140028"],"award-info":[{"award-number":["SBO-140028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s11302-020-09716-z","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T07:38:12Z","timestamp":1595921892000},"page":"379-387","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Involvement of adenosine A1 and A2A receptors on guanosine-mediated anti-tremor effects in reserpinized mice"],"prefix":"10.1007","volume":"16","author":[{"given":"C. M.","family":"Massari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. C.","family":"Constantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. F.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. B.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Valle-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"L\u00f3pez-Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Fern\u00e1ndez-Due\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ciruela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3414-6150","authenticated-orcid":false,"given":"C. I.","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"9716_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0140-6736(92)90457-E","volume":"340","author":"EC Hirsch","year":"1992","unstructured":"Hirsch EC, Mouatt A, Faucheux B, Bonnet AM, Javoy-Agid F, Graybiel AM, Agid Y (1992) Dopamine, tremor, and Parkinson\u2019s disease. Lancet 340:125\u2013126","journal-title":"Lancet"},{"issue":"Suppl 5","key":"9716_CR2","doi-asserted-by":"crossref","first-page":"V33","DOI":"10.1007\/PL00007781","volume":"247","author":"G Deuschl","year":"2000","unstructured":"Deuschl G, Raethjen J, Baron R, Lindemann M, Wilms H, Krack P (2000) The pathophysiology of parkinsonian tremor: a review. J Neurol 247(Suppl 5):V33\u2013V48","journal-title":"J Neurol"},{"key":"9716_CR3","first-page":"49","volume":"5","author":"LE Collins-Praino","year":"2011","unstructured":"Collins-Praino LE, Paul NE, Rychalsky KL, Hinman JR, Chrobak JJ, Senatus PB, Salamone JD (2011) Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor. Front Syst Neurosci 5:49","journal-title":"Front Syst Neurosci"},{"key":"9716_CR4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0301-0082(98)00053-7","volume":"56","author":"JD Salamone","year":"1998","unstructured":"Salamone JD, Mayorga AJ, Trevitt JT, Cousins MS, Conlan A, Nawab A (1998) Tremulous jaw movements in rats: a model of parkinsonian tremor. Prog Neurobiol 56:591\u2013611","journal-title":"Prog Neurobiol"},{"key":"9716_CR5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.18773\/austprescr.2019.014","volume":"42","author":"SR Duma","year":"2019","unstructured":"Duma SR, Fung VS (2019) Drug-induced movement disorders. Aust Prescr 42:56\u201361","journal-title":"Aust Prescr"},{"key":"9716_CR6","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/0028-3908(87)90110-9","volume":"26","author":"FC Colpaert","year":"1987","unstructured":"Colpaert FC (1987) Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat. Neuropharmacology 26:1431\u20131440","journal-title":"Neuropharmacology"},{"key":"9716_CR7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11302-007-9093-8","volume":"4","author":"S Jiang","year":"2008","unstructured":"Jiang S, Ballerini P, Buccella S, Giuliani P, Jiang C, Huang X, Rathbone MP (2008) Remyelination after chronic spinal cord injury is associated with proliferation of endogenous adult progenitor cells after systemic administration of guanosine. Purinergic Signal 4:61\u201371","journal-title":"Purinergic Signal"},{"key":"9716_CR8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pharmthera.2007.07.004","volume":"116","author":"AP Schmidt","year":"2007","unstructured":"Schmidt AP, Lara DR, Souza DO (2007) Proposal of a guanine-based purinergic system in the mammalian central nervous system. Pharmacol Ther 116:401\u2013416","journal-title":"Pharmacol Ther"},{"key":"9716_CR9","doi-asserted-by":"crossref","unstructured":"Lanznaster D, Mack JM, Coelho V, Ganzella M, Almeida RF, Dal-Cim T, Hansel G, Zimmer ER, Souza DO, Prediger RD, Tasca CI (2016) Guanosine prevents anhedonic-like behavior and impairment in hippocampal glutamate transport following amyloid-\u03b21\u201340 administration in mice. Mol Neurobiol","DOI":"10.1007\/s12035-016-0082-1"},{"key":"9716_CR10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(01)02734-2","volume":"912","author":"DR Lara","year":"2001","unstructured":"Lara DR, Schmidt AP, Frizzo ME, Burgos JS, Ram\u00edrez G, Souza DO (2001) Effect of orally administered guanosine on seizures and death induced by glutamatergic agents. Brain Res 912:176\u2013180","journal-title":"Brain Res"},{"key":"9716_CR11","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1476-5381.2009.00597.x","volume":"159","author":"AP Schmidt","year":"2010","unstructured":"Schmidt AP, B\u00f6hmer AE, Schallenberger C, Antunes C, Tavares RG, Wofchuk ST, Elisabetsky E, Souza DO (2010) Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice. Br J Pharmacol 159:1247\u20131263","journal-title":"Br J Pharmacol"},{"key":"9716_CR12","doi-asserted-by":"crossref","unstructured":"Almeida RF, Comasseto DD, Ramos DB, Hansel G, Zimmer ER, Loureiro SO, Ganzella M, Souza DO (2016) Guanosine anxiolytic-like effect involves adenosinergic and glutamatergic neurotransmitter systems. Mol Neurobiol","DOI":"10.1007\/s12035-015-9660-x"},{"key":"9716_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2014.10.002","volume":"127","author":"LE Bettio","year":"2014","unstructured":"Bettio LE, Freitas AE, Neis VB, Santos DB, Ribeiro CM, Rosa PB, Farina M, Rodrigues AL (2014) Guanosine prevents behavioral alterations in the forced swimming test and hippocampal oxidative damage induced by acute restraint stress. Pharmacol Biochem Behav 127:7\u201314","journal-title":"Pharmacol Biochem Behav"},{"key":"9716_CR14","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3389\/fphar.2017.00700","volume":"8","author":"CM Massari","year":"2017","unstructured":"Massari CM, L\u00f3pez-Cano M, N\u00fa\u00f1ez F, Fern\u00e1ndez-Due\u00f1as V, Tasca CI, Ciruela F (2017) Antiparkinsonian efficacy of guanosine in rodent models of movement disorder. Front Pharmacol 8:700","journal-title":"Front Pharmacol"},{"key":"9716_CR15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12640-018-9976-1","volume":"35","author":"NF Marques","year":"2019","unstructured":"Marques NF, Massari CM, Tasca CI (2019) Guanosine protects striatal slices against 6-OHDA-induced oxidative damage, mitochondrial dysfunction, and ATP depletion. Neurotox Res 35:475\u2013483","journal-title":"Neurotox Res"},{"key":"9716_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/5584_2014_73","volume":"837","author":"P Giuliani","year":"2015","unstructured":"Giuliani P, Ballerini P, Buccella S, Ciccarelli R, Rathbone MP, Romano S, D'Alimonte I, Caciagli F, Di Iorio P, Pokorski M (2015) Guanosine protects glial cells against 6-hydroxydopamine toxicity. Adv Exp Med Biol 837:23\u201333","journal-title":"Adv Exp Med Biol"},{"key":"9716_CR17","first-page":"43","volume":"54","author":"P Giuliani","year":"2012","unstructured":"Giuliani P, Romano S, Ballerini P, Ciccarelli R, Petragnani N, Cicchitti S, Zuccarini M, Jiang S, Rathbone MP, Caciagli F, Di Iorio P (2012) Protective activity of guanosine in an in vitro model of Parkinson\u2019s disease. Panminerva Med 54:43\u201351","journal-title":"Panminerva Med"},{"key":"9716_CR18","doi-asserted-by":"crossref","unstructured":"Dal-Cim T, Poluceno GG, Lanznaster D, de Oliveira KA, Nedel CB, Tasca CI (2019) Guanosine prevents oxidative damage and glutamate uptake impairment induced by oxygen\/glucose deprivation in cortical astrocyte cultures: involvement of A. Purinergic Signal","DOI":"10.1007\/s11302-019-09679-w"},{"key":"9716_CR19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/jnc.12324","volume":"126","author":"T Dal-Cim","year":"2013","unstructured":"Dal-Cim T, Ludka FK, Martins WC, Reginato C, Parada E, Egea J, L\u00f3pez MG, Tasca CI (2013) Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions. J Neurochem 126:437\u2013450","journal-title":"J Neurochem"},{"key":"9716_CR20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/WNF.0000000000000249","volume":"40","author":"I Yabe","year":"2017","unstructured":"Yabe I, Kitagawa M, Takahashi I, Matsushima M, Sasaki H (2017) The efficacy of istradefylline for treating mild wearing-off in Parkinson disease. Clin Neuropharmacol 40:261\u2013263","journal-title":"Clin Neuropharmacol"},{"key":"9716_CR21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2017.12.027","volume":"385","author":"K Suzuki","year":"2018","unstructured":"Suzuki K, Miyamoto T, Miyamoto M, Uchiyama T, Hirata K (2018) Could istradefylline be a treatment option for postural abnormalities in mid-stage Parkinson's disease? J Neurol Sci 385:131\u2013133","journal-title":"J Neurol Sci"},{"key":"9716_CR22","doi-asserted-by":"crossref","unstructured":"T. M. Palmer and G. L. Stiles, \"Adenosine receptors,\" Neuropharmacology, vol. 34, pp. 683\u2013694, 1995","DOI":"10.1016\/0028-3908(95)00044-7"},{"key":"9716_CR23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/syn.10162","volume":"47","author":"U Kr\u00fcgel","year":"2003","unstructured":"Kr\u00fcgel U, Kittner H, Franke H, Illes P (2003) Purinergic modulation of neuronal activity in the mesolimbic dopaminergic system in vivo. Synapse 47:134\u2013142","journal-title":"Synapse"},{"key":"9716_CR24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0306-4522(92)90291-9","volume":"51","author":"S Ferr\u00e9","year":"1992","unstructured":"Ferr\u00e9 S, Fuxe K, von Euler G, Johansson B, Fredholm BB (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51:501\u2013512","journal-title":"Neuroscience"},{"key":"9716_CR25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3940(96)13143-8","volume":"218","author":"P Popoli","year":"1996","unstructured":"Popoli P, Gim\u00e9nez-Llort L, Pezzola A, Reggio R, Mart\u00ednez E, Fuxe K, Ferr\u00e9 S (1996) Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents. Neurosci Lett 218:209\u2013213","journal-title":"Neurosci Lett"},{"key":"9716_CR26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1385\/JMN:26:2-3:209","volume":"26","author":"K Fuxe","year":"2005","unstructured":"Fuxe K, Ferr\u00e9 S, Canals M, Torvinen M, Terasmaa A, Marcellino D, Goldberg SR, Staines W, Jacobsen KX, Lluis C, Woods AS, Agnati LF, Franco R (2005) Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J Mol Neurosci 26:209\u2013220","journal-title":"J Mol Neurosci"},{"key":"9716_CR27","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Due\u00f1as V, G\u00f3mez-Soler M, Valle-Le\u00f3n M, Watanabe M, Ferrer I, Ciruela F (2019) Revealing adenosine A. Int J Mol Sci 20","DOI":"10.3390\/ijms20143600"},{"key":"9716_CR28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/caff.2019.0008","volume":"9","author":"S Ferr\u00e9","year":"2019","unstructured":"Ferr\u00e9 S, Ciruela F (2019) Functional and neuroprotective role of striatal adenosine a. J Caffeine Adenosine Res 9:89\u201397","journal-title":"J Caffeine Adenosine Res"},{"key":"9716_CR29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ilar.38.1.41","volume":"38","author":"JD Clark","year":"1997","unstructured":"Clark JD, Gebhart GF, Gonder JC, Keeling ME, Kohn DF (1997) Special report: the 1996 guide for the care and use of laboratory animals. ILAR J 38:41\u201348","journal-title":"ILAR J"},{"key":"9716_CR30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0278-5846(02)00344-5","volume":"27","author":"ME Burger","year":"2003","unstructured":"Burger ME, Alves A, Callegari L, Athayde FR, Nogueira CW, Zeni G, Rocha JB (2003) Ebselen attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum. Prog Neuro-Psychopharmacol Biol Psychiatry 27:135\u2013140","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9716_CR31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbr.2016.06.014","volume":"312","author":"AS Cunha","year":"2016","unstructured":"Cunha AS, Matheus FC, Moretti M, Sampaio TB, Poli A, Santos DB, Colle D, Cunha MP, Blum-Silva CH, Sandjo LP, Reginatto FH, Rodrigues AL, Farina M, Prediger RD (2016) Agmatine attenuates reserpine-induced oral dyskinesia in mice: role of oxidative stress, nitric oxide and glutamate NMDA receptors. Behav Brain Res 312:64\u201376","journal-title":"Behav Brain Res"},{"key":"9716_CR32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pbb.2009.11.011","volume":"94","author":"LE Collins","year":"2010","unstructured":"Collins LE, Galtieri DJ, Brennum LT, Sager TN, Hockemeyer J, M\u00fcller CE, Hinman JR, Chrobak JJ, Salamone JD (2010) Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX. Pharmacol Biochem Behav 94:561\u2013569","journal-title":"Pharmacol Biochem Behav"},{"key":"9716_CR33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0091-3057(95)00164-6","volume":"53","author":"J Salamone","year":"1996","unstructured":"Salamone J, Baskin P (1996) Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible model of parkinsonian tremor. Pharmacol Biochem Behav 53:179\u2013183","journal-title":"Pharmacol Biochem Behav"},{"key":"9716_CR34","doi-asserted-by":"crossref","unstructured":"Ludka FK, Cunha MP, Dal-Cim T, Binder LB, Constantino LC, Massari CM, Martins WC, Rodrigues AL, Tasca CI (2016) Atorvastatin protects from A\u03b21\u201340-induced cell damage and depressive-like behavior via ProBDNF cleavage. Mol Neurobiol","DOI":"10.1007\/s12035-016-0134-6"},{"key":"9716_CR35","doi-asserted-by":"crossref","unstructured":"Ludka FK, Dal-Cim T, Binder LB, Constantino LC, Massari C, Tasca CI (2016) Atorvastatin and fluoxetine prevent oxidative stress and mitochondrial dysfunction evoked by glutamate toxicity in hippocampal slices. Mol Neurobiol","DOI":"10.1007\/s12035-016-9882-6"},{"key":"9716_CR36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/mds.26475","volume":"31","author":"A Pinna","year":"2016","unstructured":"Pinna A, Ko WK, Costa G, Tronci E, Fidalgo C, Simola N, Li Q, Tabrizi MA, Bezard E, Carta M, Morelli M (2016) Antidyskinetic effect of A2A and 5HT1A\/1B receptor ligands in two animal models of Parkinson\u2019s disease. Mov Disord 31:501\u2013511","journal-title":"Mov Disord"},{"key":"9716_CR37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/WNF.0000000000000073","volume":"38","author":"T Kondo","year":"2015","unstructured":"Kondo T, Mizuno Y, J. I. S. Group (2015) A long-term study of istradefylline safety and efficacy in patients with Parkinson disease. Clin Neuropharmacol 38:41\u201346","journal-title":"Clin Neuropharmacol"},{"key":"9716_CR38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbr.2015.04.001","volume":"288","author":"J Gand\u00eda","year":"2015","unstructured":"Gand\u00eda J, Morat\u00f3 X, Stagljar I, Fern\u00e1ndez-Due\u00f1as V, Ciruela F (2015) Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson\u2019s disease-associated GPR37 receptor-dependent. Behav Brain Res 288:103\u2013106","journal-title":"Behav Brain Res"},{"key":"9716_CR39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0091-3057(96)00225-0","volume":"56","author":"AJ Mayorga","year":"1997","unstructured":"Mayorga AJ, Carriero DL, Cousins MS, Gianutsos G, Salamone JD (1997) Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects. Pharmacol Biochem Behav 56:273\u2013279","journal-title":"Pharmacol Biochem Behav"},{"key":"9716_CR40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s002130050921","volume":"143","author":"AJ Mayorga","year":"1999","unstructured":"Mayorga AJ, Trevitt JT, Conlan A, Gianutsos G, Salamone JD (1999) Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats. Psychopharmacology (Berl) 143:72\u201381","journal-title":"Psychopharmacology (Berl)"},{"key":"9716_CR41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pbb.2009.07.001","volume":"94","author":"J Trevitt","year":"2009","unstructured":"Trevitt J, Kawa K, Jalali A, Larsen C (2009) Differential effects of adenosine antagonists in two models of parkinsonian tremor. Pharmacol Biochem Behav 94:24\u201329","journal-title":"Pharmacol Biochem Behav"},{"key":"9716_CR42","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0306-4522(03)00218-5","volume":"119","author":"BB Carlson","year":"2003","unstructured":"Carlson BB, Behrstock S, Tobin AJ, Salamone JD (2003) Brain implantations of engineered GABA-releasing cells suppress tremor in an animal model of Parkinsonism. Neuroscience 119:927\u2013932","journal-title":"Neuroscience"},{"key":"9716_CR43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00213-002-1247-3","volume":"165","author":"BB Carlson","year":"2003","unstructured":"Carlson BB, Wisniecki A, Salamone JD (2003) Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor. Psychopharmacology (Berl) 165:229\u2013237","journal-title":"Psychopharmacology (Berl)"},{"key":"9716_CR44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuropharm.2015.05.028","volume":"104","author":"S Ferr\u00e9","year":"2016","unstructured":"Ferr\u00e9 S, Bonaventura J, Tomasi D, Navarro G, Moreno E, Cort\u00e9s A, Llu\u00eds C, Casad\u00f3 V, Volkow ND (2016) Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer. Neuropharmacology 104:154\u2013160","journal-title":"Neuropharmacology"},{"key":"9716_CR45","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0306-4522(97)00180-2","volume":"80","author":"P Svenningsson","year":"1997","unstructured":"Svenningsson P, Le Moine C, Kull B, Sunahara R, Bloch B, Fredholm BB (1997) Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience 80:1171\u20131185","journal-title":"Neuroscience"},{"key":"9716_CR46","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1476-5381.1996.tb15561.x","volume":"118","author":"AK Dixon","year":"1996","unstructured":"Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, Freeman TC (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118:1461\u20131468","journal-title":"Br J Pharmacol"},{"key":"9716_CR47","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.euroneuro.2012.08.004","volume":"23","author":"JD Salamone","year":"2013","unstructured":"Salamone JD, Collins-Praino LE, Pardo M, Podurgiel SJ, Baqi Y, M\u00fcller CE, Schwarzschild MA, Correa M (2013) Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor. Eur Neuropsychopharmacol 23:972\u2013977","journal-title":"Eur Neuropsychopharmacol"},{"key":"9716_CR48","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1111\/ejn.12212","volume":"38","author":"LE Collins-Praino","year":"2013","unstructured":"Collins-Praino LE, Paul NE, Ledgard F, Podurgiel SJ, Kovner R, Baqi Y, M\u00fcller CE, Senatus PB, Salamone JD (2013) Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism. Eur J Neurosci 38:2183\u20132191","journal-title":"Eur J Neurosci"},{"key":"9716_CR49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001756-199412300-00020","volume":"6","author":"S Ferr\u00e9","year":"1994","unstructured":"Ferr\u00e9 S, Popoli P, Gim\u00e9nez-Llort L, Finnman UB, Mart\u00ednez E, Scotti de Carolis A, Fuxe K (1994) Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors. Neuroreport 6:73\u201376","journal-title":"Neuroreport"},{"key":"9716_CR50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3940(96)12577-5","volume":"208","author":"S Ferre","year":"1996","unstructured":"Ferre S, Popoli P, Tinner-Staines B, Fuxe K (1996) Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sites. Neurosci Lett 208:109\u2013112","journal-title":"Neurosci Lett"},{"key":"9716_CR51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2004.06.030","volume":"497","author":"N Ismayilova","year":"2004","unstructured":"Ismayilova N, Crossman A, Verkhratsky A, Brotchie J (2004) Effects of adenosine A1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised rats. Eur J Pharmacol 497:187\u2013195","journal-title":"Eur J Pharmacol"},{"key":"9716_CR52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(89)90041-3","volume":"483","author":"C Missale","year":"1989","unstructured":"Missale C, Nisoli E, Liberini P, Rizzonelli P, Memo M, Buonamici M, Rossi A, Spano P (1989) Repeated reserpine administration up-regulates the transduction mechanisms of D1 receptors without changing the density of [3H]SCH 23390 binding. Brain Res 483:117\u2013122","journal-title":"Brain Res"},{"key":"9716_CR53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0197-0186(89)90010-7","volume":"14","author":"P Liberini","year":"1989","unstructured":"Liberini P, Nisoli E, Missale C, Memo M, Buonamici M, Rossi A, Spano PF (1989) Differential effect of acute reserpine administration on D-1 and D-2 dopaminergic receptor density and function in rat striatum. Neurochem Int 14:61\u201364","journal-title":"Neurochem Int"},{"key":"9716_CR54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1478-811X-11-34","volume":"11","author":"J Meiser","year":"2013","unstructured":"Meiser J, Weindl D, Hiller K (2013) Complexity of dopamine metabolism. Cell Commun Signal 11:34","journal-title":"Cell Commun Signal"},{"key":"9716_CR55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pbb.2008.11.015","volume":"92","author":"AM Teixeira","year":"2009","unstructured":"Teixeira AM, Reckziegel P, M\u00fcller L, Pereira RP, Roos DH, Rocha JB, B\u00fcrger ME (2009) Intense exercise potentiates oxidative stress in striatum of reserpine-treated animals. Pharmacol Biochem Behav 92:231\u2013235","journal-title":"Pharmacol Biochem Behav"},{"key":"9716_CR56","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/jnr.21883","volume":"87","author":"C Su","year":"2009","unstructured":"Su C, Elfeki N, Ballerini P, D'Alimonte I, Bau C, Ciccarelli R, Caciagli F, Gabriele J, Jiang S (2009) Guanosine improves motor behavior, reduces apoptosis, and stimulates neurogenesis in rats with parkinsonism. J Neurosci Res 87:617\u2013625","journal-title":"J Neurosci Res"},{"key":"9716_CR57","doi-asserted-by":"crossref","unstructured":"Lanznaster D, Massari CM, Markov\u00e1 V, \u0160imkov\u00e1 T, Duroux R, Jacobson KA, Fern\u00e1ndez-Due\u00f1as V, Tasca CI, Ciruela F (2019) Adenosine A. Cells 8","DOI":"10.3390\/cells8121630"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-020-09716-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-020-09716-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-020-09716-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T23:32:55Z","timestamp":1627428775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-020-09716-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["9716"],"URL":"https:\/\/doi.org\/10.1007\/s11302-020-09716-z","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"assertion":[{"value":"24 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Ethical Committee on Animal Use and Care of the University of Barcelona (CEEA\/UB) and Federal University of Santa Catarina (CEUA\/UFSC, Protocol PP00955).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}